The purchase is too small relative to market cap to be a strong standalone signal, but the insider's 10% owner status and recent buying pattern warrant monitoring. Watch for additional insider purchases or a material catalyst (e.g., pipeline update, partnership) that could confirm the bullish view. The next catalyst to watch is the upcoming earnings or clinical data readout.
PRTA drugs
PRTA drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 4 $9.82entry
- T+1 · 2mo ago −2.85%α −2.30% · $9.54
- T+5 · 2mo ago −9.78%α −8.57% · $8.86
- T+20 · 6w ago −15.78%α −16.39% · $8.27
- T+50 · todayOpen
- T+60 · in 14d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
William P. Scully, a 10% owner of Prothena, purchased 27,000 shares on the open market for approximately $256K at $9.47/share. This is a standalone conviction buy from a major insider, representing about 0.05% of the company's $497M market cap, which is below the 0.1% threshold for materiality.
Key Financial Metrics
Key Facts
- 10% owner William P. Scully purchased 27,000 shares at $9.47/share for $256K on 2026-09-02.
- The purchase represents ~0.05% of PRTA's $497M market cap, below the 0.1% materiality threshold.
- This is a single insider buy, not a cluster; the broader 30-day insider activity shows $1.0M in total buys.
Financial Impact
$256K open-market purchase by 10% owner, representing ~0.05% of market cap
Risk Factors
- Purchase is modest at 0.05% of market cap, limiting its signaling power.
- No accompanying material corporate event (e.g., earnings, pipeline update) to contextualize the buy.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0001045463-26-000015 |
Track record
20 reports on PRTA
8 of 12 bullish or bearish reports moved the stock their way by T+1. Best: +14.11% at T+60 after the Jun 12, 2026 report. 9 of 12 went positive at some point.
Filters
- Nov 13, 20263d ago 3 Neutral 1/10 Entry $8.16 to $7.97 Now $7.97 −2.33% ▼ −2.33% −0.42% vs SPY
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $8.16 to $7.97 Now $7.97 −2.33% ▼ −2.33% −0.42% vs SPY
- Nov 10, 20266d ago Insider Buy Bullish 5/10 Entry $8.56 to $8.73 Now $7.97 −6.89% ▲ +1.99% +0.67% vs SPY
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $7.97 to $8.78 Now $7.97 −0.00% ▲ +10.10% +7.73% vs SPY
- Oct 29, 202618d ago 8-K Bearish 6/10 Entry $8.47 to $8.29 Now $7.97 +5.90% ▲ +2.13% +1.65% vs SPY
- Oct 26, 202621d ago Insider Buy Bullish 5/10 Entry $8.81 to $9.10 Now $7.97 −9.53% ▲ +3.29% +2.95% vs SPY
- Oct 15, 20264w ago Insider Buy Bullish 5/10 Entry $8.35 to $8.48 Now $7.97 −4.55% ▲ +1.56% +1.13% vs SPY
- Sep 30, 20266w ago Insider Buy Bullish 5/10 Entry $8.54 to $8.36 Now $7.97 −6.67% ▼ −2.11% −2.85% vs SPY
- Sep 29, 20266w ago Insider Buy Bullish 5/10 Entry $8.38 to $8.54 Now $7.97 −4.89% ▲ +1.91% +1.73% vs SPY
- Sep 21, 20268w ago Insider Buy Bullish 6/10 Entry $8.99 to $8.68 Now $7.97 −11.35% ▼ −3.45% −2.73% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers